Serious pulmonary toxicity in patients with Hodgkin's lymphoma with SGN-30, gemcitabine, vinorelbine, and liposomal doxorubicin is associated with an FcγRIIIa-158 V/F polymorphism.
about
Customized targeted therapy in Hodgkin lymphoma: hype or hope?Diagnostic, prognostic and therapeutic role of CD30 in lymphoma.Hodgkin's lymphoma therapy: past, present, and future.MiR-SNPs as markers of toxicity and clinical outcome in Hodgkin lymphoma patientsEmerging Pharmacotherapy for Relapsed or Refractory Hodgkin's Lymphoma: Focus on Brentuximab VedotinClinical targeting of the TNF and TNFR superfamiliesTreatment challenges in the management of relapsed or refractory non-Hodgkin's lymphoma - novel and emerging therapies.Targetable molecular pathways in classical Hodgkin's lymphoma.New antibody drug treatments for lymphoma.CD30: an important new target in hematologic malignancies.Where does brentuximab vedotin fit into the management of patients with Hodgkin lymphoma?Brentuximab vedotinBrentuximab vedotin in Hodgkin's lymphoma.New strategies in Hodgkin lymphoma: better risk profiling and novel treatments.CD30 as a therapeutic target for lymphoma.Managing Hodgkin lymphoma relapsing after autologous hematopoietic cell transplantation: a not-so-good cancer after all!Role of CD30 targeting in malignant lymphoma.An update on emerging drugs for Hodgkin lymphoma.Antibodies and antibody-drug conjugates in the treatment of Hodgkin lymphoma.Brentuximab vedotin for treating Hodgkin's lymphoma: an analysis of pharmacology and clinical efficacy.CD30 and CD30-Targeted Therapies in Hodgkin Lymphoma and Other B cell Lymphomas.Brentuximab vedotin and AVD followed by involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma.Digging up the human genome: current progress in deciphering adverse drug reactions.Brentuximab Vedotin in CD30+ Lymphomas.
P2860
Q27002554-91C189DD-9EAB-47A0-8B34-A84887B36B54Q30240160-785DF401-FB1F-4318-859F-5DE8A447B075Q34296914-20B29DB6-0F5F-4D71-AD12-A56EC920CDA4Q34738140-961CB68D-0E3E-44AE-BF22-1B5A3AEA3CB9Q35669134-9B5453E1-4973-456B-AB5B-6918E19E38B7Q36762882-D2A4E703-A200-4ACF-82FA-703A55374C0EQ37178611-DF51716F-561D-4DB0-A61D-73BA4568CA16Q37825891-56B74F6C-D4A5-4E64-AEED-EE859AC326EBQ37852003-EDF6AE81-36A8-4A50-BC58-4ECF609665F5Q37880873-DF85CB80-1CB9-414D-A43A-E99C54E750DBQ38016373-49552BB2-1DD9-472C-BE9D-BFC42ABD2498Q38017578-0EFDC1B0-DE24-488E-80F0-05B5C5927D0DQ38039452-686B669D-CFD7-4E45-96C1-91DDD6F615C8Q38085250-705727EC-A83A-4AD2-A8E7-FE6112C35247Q38138482-DDC8D4BA-51B9-483C-AEBD-11F7F9AA84DCQ38179975-D8DFB3A7-A615-4595-B8CE-788612CDF199Q38191191-AA522DEB-4840-42C0-8E23-67B7AD30F005Q38205874-7E521ED9-05C7-49A4-8638-E691C64FD7BAQ38205923-83085C39-843C-4CD7-B597-E2A785B09C6BQ38340900-92316473-31EB-49C8-9BF6-47FBA4E13BD2Q38950501-A25BA436-38E7-4186-BD47-AE230AD5D5A0Q41108261-255EC0CB-3150-4D93-BF61-18D4584250FDQ41889353-15305FE1-C1D5-4003-A918-A0440E4931D7Q42775414-FC3975C2-AE81-43E5-BD99-E12939FA0300
P2860
Serious pulmonary toxicity in patients with Hodgkin's lymphoma with SGN-30, gemcitabine, vinorelbine, and liposomal doxorubicin is associated with an FcγRIIIa-158 V/F polymorphism.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Serious pulmonary toxicity in ...... FcγRIIIa-158 V/F polymorphism.
@ast
Serious pulmonary toxicity in ...... FcγRIIIa-158 V/F polymorphism.
@en
Serious pulmonary toxicity in ...... FcγRIIIa-158 V/F polymorphism.
@nl
type
label
Serious pulmonary toxicity in ...... FcγRIIIa-158 V/F polymorphism.
@ast
Serious pulmonary toxicity in ...... FcγRIIIa-158 V/F polymorphism.
@en
Serious pulmonary toxicity in ...... FcγRIIIa-158 V/F polymorphism.
@nl
prefLabel
Serious pulmonary toxicity in ...... FcγRIIIa-158 V/F polymorphism.
@ast
Serious pulmonary toxicity in ...... FcγRIIIa-158 V/F polymorphism.
@en
Serious pulmonary toxicity in ...... FcγRIIIa-158 V/F polymorphism.
@nl
P2093
P2860
P356
P1433
P1476
Serious pulmonary toxicity in ...... FcγRIIIa-158 V/F polymorphism.
@en
P2093
B D Cheson
J L Johnson
N L Bartlett
P2860
P304
P356
10.1093/ANNONC/MDQ211
P577
2010-04-27T00:00:00Z